May 22 (Reuters) - Medexus Pharmaceuticals Inc MDP.V :
* MEDEXUS PROVIDES AN UPDATE ON THE IXINITY® ACQUISITION AND
ITS
OVERALL BUSINESS IN THE COVID-19 ENVIRONMENT
* MEDEXUS PHARMACEUTICALS INC - INTEGRATION OF IXINITY IS
PROGRESSING IN LINE WITH EXPECTATIONS
* MEDEXUS PHARMACEUTICALS INC - CONTINUE TO GENERATE STEADY
GROWTH
ACROSS KEY PRODUCT LINES
* MEDEXUS PHARMACEUTICALS - NOT AWARE OF ANY DISRUPTION TO
SUPPLY
OF ANY OF ITS PRODUCTS TO PATIENTS
Source text for Eikon: ID:nGNX8z3dsN
Further company coverage: MDP.V
((Reuters.Briefs@thomsonreuters.com;))